Kyleh Ambert News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MindMed (OTCQB:MMEDF) released its full-year 2020 financial results.  The company posted a net and comprehensive loss of $35.1 million for the year ended Dec. 31, 2020. Its total assets at the end of the reporting period were $85.6 million, counting $80.1 million in cash. The company used $24.2 million of net cash in operating activities in 2020. Its cash balance as of Tuesday last week hovered at $161 million. The company plans to use the money to improve its portfolio and develop its technology sector. On Monday, MindMed also revealed the results of a study on personalized MDMA dosing, con...

Nova Mentis Launches Autism Microbiome Study in the United States News provided by Share this article Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF)  ("NOVA" or the "Company"), a leader in the development of psilocybin and other entheogens, is pleased to announce the launch of its US-based Observational Study NM-101: " Microbiotic Diversity in Autism Spectrum Disorder (ASD): Improving Diagnostics by Differentiating Subtypes." "NOVA's mission is to discover more precise ways to diagnose and treat autism spectrum disorder (ASD), an unmet medical need," stated Julia V. ...